發(fā)布時(shí)間：2018-11-20 06:38

【摘要】：目的探討抑制內(nèi)質(zhì)網(wǎng)應(yīng)激肌醇必需酶-1(IRE-1)信號(hào)通路在野百合堿誘導(dǎo)大鼠肺動(dòng)脈高壓發(fā)生、發(fā)展中的作用機(jī)制。方法選擇Wistar雄性大鼠,隨機(jī)分為正常對(duì)照組、模型組、藥物治療組。采用一次性腹腔注射野百合堿的方法建立肺動(dòng)脈高壓模型。藥物治療組在建模2周后給予灌服4-苯基丁酸2周。檢測(cè)各組大鼠血流動(dòng)力學(xué)、病理形態(tài)學(xué)及IRE-1信號(hào)通路中關(guān)鍵因子葡萄糖調(diào)節(jié)蛋白78(GRP78)、IRE-1α的mRNA相對(duì)表達(dá)量。結(jié)果腹腔注射野百合堿建立肺動(dòng)脈高壓模型后,模型組平均肺動(dòng)脈壓力(m PAP)、平均右心室壓力(mRVP)較正常對(duì)照組顯著升高(P0.001),病理肺血管重塑指標(biāo)較正常對(duì)照組增高(P0.001),GRP78和IRE-1αmRNA相對(duì)表達(dá)量較正常對(duì)照組升高(P0.05,P0.001)。經(jīng)過(guò)化學(xué)分子伴侶4-苯基丁酸干預(yù)后,藥物治療組血流動(dòng)力學(xué)指標(biāo)較模型組減低(P0.01),但未恢復(fù)到正常對(duì)照組水平(P0.001);病理檢測(cè)肺小動(dòng)脈中膜厚度、管壁面積/管總面積與模型組相比減少(P0.001),可恢復(fù)到正常對(duì)照組水平(P0.05),右室肥厚指數(shù)與模型組相比減少(P0.001),未恢復(fù)到正常對(duì)照組水平(P0.001);GRP78、IRE-1α的mRNA相對(duì)表達(dá)量較模型組降低(P0.05,P0.001),可恢復(fù)到正常對(duì)照組水平(P0.05)。結(jié)論內(nèi)質(zhì)網(wǎng)應(yīng)激IRE-1信號(hào)通路在肺動(dòng)脈高壓發(fā)生、發(fā)展中發(fā)揮重要作用,通過(guò)化學(xué)分子伴侶4-苯基丁酸的抑制,可以有效降低肺動(dòng)脈高壓,減輕肺小動(dòng)脈重塑。
[Abstract]:Objective to investigate the mechanism of inhibition of endoplasmic reticulum stress inositol essential enzyme 1 (IRE-1) signaling pathway in monocrotaline induced pulmonary hypertension in rats. Methods male Wistar rats were randomly divided into normal control group, model group and drug treatment group. Pulmonary hypertension model was established by a single intraperitoneal injection of monocrotaline. The drug treatment group was given 4-phenyl butyric acid for 2 weeks after modeling. The relative expression of glucose regulatory protein 78 (GRP78) and IRE-1 偽 in IRE-1 signaling pathway and hemodynamics were measured. Results after intraperitoneal injection of monocrotaline, the mean pulmonary artery pressure (m PAP),) and right ventricular pressure (mRVP) in the model group were significantly higher than those in the control group (P0.001). The pathological pulmonary vascular remodeling index was higher than that of the normal control group (P0.001), and the relative expression of GRP78 and IRE-1 偽 mRNA was higher than that of the normal control group (P0.05, P0.001). After the intervention of 4-phenylbutyric acid, the hemodynamic index of the drug treatment group was lower than that of the model group (P0.01), but did not return to the normal control level (P0.001). Compared with the model group, the thickness of medial membrane of pulmonary arteriole, the area of the wall / the total area of the tube were decreased (P0.001), and the index of right ventricular hypertrophy was decreased (P0.001) in the normal control group (P0.05). Did not return to the normal control level (P0.001); The relative mRNA expression of GRP78,IRE-1 偽 was lower than that of the model group (P0.05, P0.001), and could return to the normal control level (P0.05). Conclusion endoplasmic reticulum stress IRE-1 signaling pathway plays an important role in the pathogenesis and development of pulmonary hypertension. Inhibition of 4-phenylbutyric acid by chemical molecular chaperones can effectively reduce pulmonary hypertension and alleviate pulmonary arterioles remodeling.
【作者單位】： 新疆醫(yī)科大學(xué)第一附屬醫(yī)院藥學(xué)部;新疆醫(yī)科大學(xué)基礎(chǔ)醫(yī)學(xué)院;新疆醫(yī)科大學(xué)第一附屬醫(yī)院全科醫(yī)學(xué)科;
【基金】：新疆維吾爾自治區(qū)自然科學(xué)基金青年科學(xué)基金項(xiàng)目(編號(hào):2014211C071)
【分類號(hào)】：R544.1

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 黃震華;肺動(dòng)脈高壓治療進(jìn)展[J];高原醫(yī)學(xué)雜志;2001年01期

2 袁志明;阻塞性睡眠呼吸暫停綜合征與肺動(dòng)脈高壓研究進(jìn)展[J];國(guó)外醫(yī)學(xué).呼吸系統(tǒng)分冊(cè);2002年03期

3 郭明好,牛文革,劉云,劉向東,許清玉,楊磊;激素加環(huán)磷酰胺沖擊治療原發(fā)性干燥綜合征合并肺動(dòng)脈高壓5例[J];第四軍醫(yī)大學(xué)學(xué)報(bào);2003年14期

4 王虹,王祥;肺源性肺動(dòng)脈高壓研究進(jìn)展[J];江蘇醫(yī)藥;2004年09期

5 朱萍,倪松石;慢性阻塞性肺疾病并發(fā)肺動(dòng)脈高壓的治療進(jìn)展[J];中國(guó)交通醫(yī)學(xué)雜志;2004年04期

6 鄧長(zhǎng)金;混合性結(jié)締組織病致肺動(dòng)脈高壓1例[J];臨床心血管病雜志;2005年04期

7 錢衛(wèi)民;珠蛋白生成障礙性貧血合并肺動(dòng)脈高壓1例[J];嶺南心血管病雜志;2005年05期

8 彭翠萍;;混合性結(jié)締組織病合并肺動(dòng)脈高壓1例[J];罕少疾病雜志;2005年06期

9 劉超,劉剛,劉坤申;內(nèi)皮素受體拮抗劑與肺動(dòng)脈高壓的治療[J];中國(guó)實(shí)用內(nèi)科雜志;2005年01期

10 陸慰萱;;肺動(dòng)脈高壓的新分類[J];中國(guó)實(shí)用內(nèi)科雜志;2006年01期

相關(guān)會(huì)議論文 前10條

1 沈敏;張p，

本文編號(hào)：2344092